Published in J Am Coll Surg on February 01, 1994
Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg (2001) 0.93
Prognosis of patients with bilateral carcinoma of the breast. J Am Coll Surg (1995) 0.75
Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science (1985) 2.77
THE UTILIZATION OF INTRAVENOUSLY INJECTED SALT IN NORMALS AND IN PATIENTS WITH CUSHING'S SYNDROME BEFORE AND AFTER ADMINISTRATION OF DESOXYCORTICOSTERONE ACETATE. J Clin Invest (1944) 2.64
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer (1977) 2.16
Stage 0 to stage III breast cancer in young women. J Am Coll Surg (2000) 1.93
Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet (1998) 1.75
A research agenda for gastrointestinal and endoscopic surgery. Surg Endosc (2007) 1.72
Awareness and attitudes concerning BRCA gene testing. Ann Surg Oncol (1999) 1.62
Cholesterol and obesity as prognostic factors in breast cancer. Cancer (1981) 1.47
Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg (1997) 1.32
Parity and prognosis in breast cancer. Cancer (1980) 1.28
Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg (1984) 1.21
The consequence of undertreating breast cancer in the elderly. J Am Coll Surg (2001) 1.20
Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg (1999) 1.11
Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase. Ann Surg (1981) 1.11
Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg (1986) 1.09
Perioperative blood transfusion has prognostic significance for breast cancer. Surgery (1985) 1.09
Complete removal of nonpalpable breast malignancies with a stereotactic percutaneous vacuum-assisted biopsy instrument. J Am Coll Surg (1999) 1.09
p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.03
The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer. Cancer Invest (1998) 1.00
Ethnic differences in risk and prognostic factors for breast cancer. Cancer (1995) 0.99
Age distribution of right- and left-sided colorectal cancers. Am J Gastroenterol (1982) 0.97
Surgery for nonpalpable breast lesions. Arch Surg (1990) 0.97
Laparoscopic resection of two liver hemangiomata. Surg Laparosc Endosc (1995) 0.95
Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease. Am J Surg (1986) 0.90
Unnecessary blood transfusions in elective colorectal cancer surgery. Transfusion (1985) 0.90
The risk of perforation when children with possible appendicitis are observed in the hospital. Surg Gynecol Obstet (1992) 0.90
The significance of family history for patients with carcinoma of the breast. J Am Coll Surg (1994) 0.89
A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study. Recent Results Cancer Res (1982) 0.89
Fecal steroid metabolites and breast cancer risk. Cancer (1982) 0.88
Complications requiring reoperation following pancreatectomy. Int J Pancreatol (1998) 0.88
Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia. Breast J (2009) 0.87
Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II). J Surg Oncol (1994) 0.85
Changes in peripheral T-cell subsets and natural-killer cytotoxicity in relation to colorectal cancer surgery. Cancer Detect Prev (1986) 0.85
Lumpectomy with tamoxifen as primary treatment for elderly women with early-stage breast cancer. Am J Surg (2000) 0.85
Chest wall resection for locally recurrent breast cancer: indications, technique, and results. J Surg Oncol (1992) 0.85
Proliferative indices and oncoprotein expression in benign and malignant breast biopsies. Ann Surg Oncol (1995) 0.83
Association between prognosis and hormone receptors in women with breast cancer. Cancer Detect Prev (1986) 0.83
Breast cancer in an intramammary sentinel node. Breast J (2001) 0.82
Postoperative infections following autologous and homologous blood transfusions. Transfusion (1992) 0.82
Identification of human leukemic glucocorticoid receptors using affinity labeling and anti-human glucocorticoid receptor antibodies. Cancer Res (1984) 0.82
Carcinoma of the breast in postmenopausal hormone user and nonuser control groups. J Am Coll Surg (1994) 0.82
Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component. Ann Surg Oncol (1995) 0.81
Breast cancer diagnosis by fine needle aspiration and excisional biopsy. Recurrence and survival. Acta Cytol (1997) 0.81
Multivariate analysis of roentgenologic characteristics and risk factors for nonpalpable carcinoma of the breast. J Am Coll Surg (1994) 0.80
Intraoperative cardiac tamponade complicating esophagogastrectomy. J Cardiovasc Surg (Torino) (1998) 0.80
When not to give radiation therapy after breast conservation surgery for breast cancer. J Surg Oncol (2000) 0.79
Cholesterol, weight, height, Quetelet's index, and colon cancer recurrence. J Surg Oncol (1984) 0.79
Operative ultrasound establishes resectability of metastases by major hepatic resection. World J Surg (1989) 0.78
Treatment strategies in myasthenia gravis. Ann N Y Acad Sci (1993) 0.78
The prognostic significance of previous benign breast disease for women with carcinoma of the breast. J Am Coll Surg (1996) 0.78
Serum cholesterol and human colon cancer. J Natl Cancer Inst (1981) 0.78
Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells. Breast Cancer Res Treat (2000) 0.78
Breast cancer and family history: a multivariate analysis of levels of tumor HER2 protein and family history of cancer in women who have breast cancer. Mt Sinai J Med (1995) 0.78
Subareolar breast cancers. Am J Surg (2000) 0.78
Randomised trial of intraperitoneal irrigation with low molecular weight povidone-iodine solution to reduce intra-abdominal infectious complications. J Hosp Infect (1985) 0.78
Breast carcinoma associated with pregnancy and lactation. Surg Oncol (1997) 0.77
Association of risk and prognostic factors in breast cancer. Prog Clin Biol Res (1977) 0.77
The significance of malignancies incidental to microcalcifications in breast spot localization biopsy specimens. Am J Surg (2001) 0.77
Decreased length of stay for patients with colorectal cancer: implications of DRG use. J Healthc Qual (1998) 0.77
Comparison of mastectomy and lumpectomy for medial carcinoma of the breast. Surg Gynecol Obstet (1991) 0.76
Breast cancer diagnosed during hormone replacement therapy. Obstet Gynecol (2000) 0.76
Perioperative transfusions associated with colorectal cancer surgery: clinical judgment versus the hematocrit. World J Surg (1986) 0.76
Sentinel lymph node biopsy. J Am Coll Surg (1998) 0.75
The use of spiral computed tomography in the evaluation of vessel encasement for pancreatic cancer. Int J Pancreatol (1996) 0.75
EFFECT OF SODIUM IODIDE, MAGNESIUM SULFATE, THYROXIN, AND THYROTROPIC HORMONE ON THE BLOOD MAGNESIUM PARTITION. J Clin Invest (1944) 0.75
Reproductive history and prognosis in patients with operable breast cancer. Cancer (1995) 0.75
Estrogens and women with breast cancer. Oncology (Williston Park) (1998) 0.75
Estrogen replacement therapy and breast cancer: analysis of age of onset and tumor characteristics. Ann Surg Oncol (1999) 0.75
Ultrasonography in sentinel lymph node biopsy. Ann Surg Oncol (1998) 0.75
Resistance of the canine common bile duct. Bull N Y Acad Med (1983) 0.75
Characterization of a novel immunocytolytic factor secreted by pancreatic adenocarcinoma. Oncol Res (1999) 0.75
Modern surgical treatment of breast cancer. Jpn J Surg (1985) 0.75
Treatment of metastatic cancer to the liver. Semin Liver Dis (1994) 0.75
Diagnosis of breast masses by physical examination, fine-needle aspiration, and excision biopsy. Cancer Detect Prev (1987) 0.75
The role of preoperative intravenous pyelogram in operations performed for carcinoma of the colon and rectum. Surg Gynecol Obstet (1986) 0.75
Determinants of success with spot localization biopsy of the breast. J Am Coll Surg (1995) 0.75
Multivariate analysis of recurrence after anterior resection for colorectal carcinoma. Am J Surg (1989) 0.75
The true cost of protective loop colostomy. Am J Gastroenterol (1989) 0.75
Surgical treatment of breast cancer. N Y State J Med (1979) 0.75
Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma. J Immunol Methods (1980) 0.75
The prognostic significance of elevated serum alkaline phosphatase levels preoperatively in patients with carcinoma of the colon and rectum. Surg Gynecol Obstet (1984) 0.75
A method of supporting venous tubing in the neck to prevent occlusion of peritoneovenous shunts. Arch Surg (1984) 0.75
A novel immunocytolytic factor secreted by pancreatic adenocarcinoma. J Surg Res (2000) 0.75